RhumbLine Advisers’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Other funds holding DTIL
LCM
RhumbLine Advisers's DTIL Position: Q3 2026 in Review
RhumbLine Advisers reduced its Precision BioSciences (DTIL) stake by 2.5% in Q3 2026, selling an estimated $5.18K and leaving 27,178 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #3339.
RhumbLine Advisers first reported a position in DTIL in Q4 2019 and has held it in 19 quarters since. The position peaked at $574K in Q2 2021. 109 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.
- RhumbLine Advisers held 27,178 shares of Precision BioSciences worth $170K as of Q3 2026.
- RhumbLine Advisers sold 686 Precision BioSciences shares in Q3 2026, an estimated $5.18K.
- Precision BioSciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3339 holding.
- RhumbLine Advisers first reported a position in Precision BioSciences in Q4 2019 and has held it in 19 quarters since.
- RhumbLine Advisers's Precision BioSciences position peaked at $574K in Q2 2021.
- 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.